Krishan Kumar
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
44
Citations
1,435
Est. group size
~2
Recurring co-author estimate
Active years
21
Publishing since 2005
This researcher's work centers on cancer cell biology, particularly pancreatic and breast cancer, examining how proteins like BET (bromodomain and extraterminal proteins) and MNK kinases regulate tumor growth, drug resistance, and processes like fibrosis and metastasis. Much of the research explores how blocking certain proteins (using 'BET inhibitors') might make existing cancer treatments more effective. The publication record also includes some clinical observation studies unrelated to this core molecular cancer biology focus.
Publication output has been modest and somewhat irregular over the last decade, with a notable gap in 2024 and generally low annual counts averaging just over one per year in the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Data from Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer
2023
- Computer Simulation and Modeling in Pharmacokinetics and Pharmacodynamics
2022
- OBSERVATION OF PROSTATE SPECIFIC ANTIGEN LEVEL ON ENLARGED PROSTATE IN RIMS RANCHI.
GLOBAL JOURNAL FOR RESEARCH ANALYSIS · 2021
- BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine
Science Translational Medicine · 2020
- CLINICO-PATHOLOGICAL RESPONSE AND OPERABILITY AFTER NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CARCINOMA
International journal of scientific research · 2020
- Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1
International Journal of Molecular Sciences · 2019
- Abstract 2086: Targeting the MNK effector hnRNPA1 enhances the efficacy of BET inhibitors in cancer cells
Experimental and Molecular Therapeutics · 2019
- Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells
Scientific Reports · 2018
- Induction of MNK Kinase–dependent eIF4E Phosphorylation by Inhibitors Targeting BET Proteins Limits Efficacy of BET Inhibitors
Molecular Cancer Therapeutics · 2018
- Abstract 4500: BET proteins regulate hyaluronan synthases in pancreatic ductal adenocarcinoma
Cancer Research · 2018
- Abstract 2989: BET inhibitors induce Rac1-dependent MNK and eIF4E phosphorylation in cancer cells
Cancer Research · 2018
- BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo
JCI Insight · 2017
- Good Documentation Practices (GDPs) in Pharmaceutical Industry
Journal of Analytical & Pharmaceutical Research · 2017
- Abstract 1679: BET inhibitors suppress PD-L1 expression in pancreatic stellate cells
Cancer Research · 2017
- Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia
Scientific Reports · 2016
- Cancer Research×4
- International Journal of Molecular Sciences×2
- Scientific Reports×2
- JCI Insight×1
- Molecular Cancer Therapeutics×1
- Hannah M. Jacobs
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Brittany Sandoval
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Bennet D. Elzey
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Guanming Jiao
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Benjamin C. Carter
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile